Trump's Autism-Tylenol Link Sparks Controversy and Market Drop
TL;DR Summary
The Trump administration is expected to claim that acetaminophen (Tylenol) use during pregnancy may increase autism risk, despite inconclusive scientific evidence, and suggest vitamin B treatment as a potential autism therapy, amid ongoing controversy and debate over medication safety and autism causes.
- The Trump administration is expected to link autism to Tylenol use during pregnancy : Shots - Health News NPR
- Kenvue’s shares fall after reports linking its Tylenol painkiller to autism Financial Times
- The drug Trump plans to promote for autism shows real (and fragile) hope The Washington Post
- White House holds briefing ahead of Trump announcement with health secretary BBC
- As Trump plans autism announcement, Tylenol maker and medical experts push back CBS News
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 3 min read
Condensed
93%
582 → 42 words
Want the full story? Read the original article
Read on NPR